Barclays PLC Takeda Pharmaceutical CO LTD Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Barclays PLC holds 1,339 shares of TAK stock, worth $17,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,339

Previous 1,339 -0.0%

Holding current value

$17,634

Previous $19,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$13.0 - $15.08 $17,381 - $20,161	1,337 Added 66850.0%	1,339 $19,000
Q4 2023 Feb 15, 2024	SELL	$13.36 - $15.43 $21,082 - $24,348	-1,578 Reduced 99.87%	2 $0
Q3 2023 Nov 07, 2023	SELL	$15.03 - $16.32 $755,347 - $820,177	-50,256 Reduced 96.95%	1,580 $24,000
Q2 2023 Aug 03, 2023	SELL	$15.57 - $17.11 $25.5 Million - $28 Million	-1,638,505 Reduced 96.93%	51,836 $814,000
Q1 2023 May 04, 2023	BUY	$15.28 - $16.48 $48,896 - $52,736	3,200 Added 0.19%	1,690,341 $27.9 Million
Q4 2022 Feb 13, 2023	SELL	$12.42 - $15.62 $36,018 - $45,298	-2,900 Reduced 0.17%	1,687,141 $26.3 Million
Q3 2022 Nov 03, 2022	BUY	$12.8 - $28.65 $39,283 - $87,926	3,069 Added 0.18%	1,690,041 $21.9 Million
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $3.33 Million - $3.78 Million	246,199 Added 17.09%	1,686,972 $24.2 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $541,115 - $673,826	-41,087 Reduced 2.77%	1,440,773 $19.6 Million
Q3 2021 Nov 09, 2021	BUY	$16.3 - $17.26 $7.07 Million - $7.49 Million	433,930 Added 41.41%	1,481,860 $24.3 Million
Q2 2021 Aug 13, 2021	BUY	$16.55 - $18.64 $7.7 Million - $8.67 Million	465,182 Added 79.83%	1,047,930 $17.6 Million
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $7.18 Million - $8.56 Million	429,929 Added 281.33%	582,748 $10.6 Million
Q4 2020 Feb 11, 2021	SELL	$15.39 - $18.97 $2.3 Million - $2.84 Million	-149,627 Reduced 49.47%	152,819 $2.78 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $11,029 - $12,377	-645 Reduced 0.21%	302,446 $5.4 Million
Q2 2020 Aug 12, 2020	SELL	$14.59 - $19.5 $523,255 - $699,348	-35,864 Reduced 10.58%	303,091 $5.43 Million
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $926,464 - $1.45 Million	-71,157 Reduced 17.35%	338,955 $5.15 Million
Q4 2019 Feb 10, 2020	SELL	$16.88 - $20.83 $406,808 - $502,002	-24,100 Reduced 5.55%	410,112 $8.09 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $2.08 Million - $2.31 Million	128,577 Added 42.07%	434,212 $7.47 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $863,420 - $1.07 Million	52,076 Added 20.54%	305,635 $5.41 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $3.88 Million - $4.99 Million	232,058 Added 1079.29%	253,559 $5.17 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $336,275 - $453,671	21,501 New	21,501 $362,000

Others Institutions Holding TAK

# of Institutions

338

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account